17572-39-3

Basic information

• Product Name: diethyl 4-hydroxy-4-Methyl-6-oxo-2-phenylcyclohexane-1,3-dicarboxylate
• Synonyms: diethyl 4-hydroxy-4-Methyl-6-oxo-2-phenylcyclohexane-1,3-dicarboxylate;2,4-Dicarbethoxy-5-hydroxy-5-methyl-3-phenylcyclohexanone;NSC 140610;Diethyl 4-hydroxy-4-methyl-6-oxo-2-phenyl-1,3-cyclohexanedicarboxylate
• CAS NO: 17572-39-3
• Molecular Formula: C₁₉H₂₄O₆
• Molecular Weight: 348.39026
• Mol File: 17572-39-3.mol

Chemical Properties

• Melting Point: 155-158℃ (ethanol )
• Boiling Point: 483.6°Cat760mmHg
• Flash Point: 167.4°C
• Appearance: /
• Density: 1.198g/cm³
• Vapor Pressure: 3.64E-10mmHg at 25°C
• Refractive Index: 1.528
• Storage Temp.: 2-8°C
• CAS DataBase Reference: diethyl 4-hydroxy-4-Methyl-6-oxo-2-phenylcyclohexane-1,3-dicarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: diethyl 4-hydroxy-4-Methyl-6-oxo-2-phenylcyclohexane-1,3-dicarboxylate(17572-39-3)
• EPA Substance Registry System: diethyl 4-hydroxy-4-Methyl-6-oxo-2-phenylcyclohexane-1,3-dicarboxylate(17572-39-3)

Safety Data

• Hazardous Substances Data: 17572-39-3(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
Diethyl 4-hydroxy-4-methyl-6-oxo-2-phenylcyclohexane-1,3-dicarboxylate is used as a building block in organic synthesis for the creation of more complex molecules. Its ester groups facilitate the synthesis process, making it a versatile component in the development of new organic compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, diethyl 4-hydroxy-4-methyl-6-oxo-2-phenylcyclohexane-1,3-dicarboxylate is used as a starting material or intermediate in drug development. Its cyclohexane ring structure and carboxylate groups are common motifs in bioactive compounds, which may contribute to the discovery of new therapeutic agents.
Used in Drug Development:
Due to its potential as a component of bioactive compounds, diethyl 4-hydroxy-4-methyl-6-oxo-2-phenylcyclohexane-1,3-dicarboxylate is used in drug development to explore its properties and applications in creating new pharmaceuticals. Its unique structure may offer novel therapeutic opportunities in various medical fields.

InChI:InChI=1/C19H24O6/c1-4-24-17(21)15-13(20)11-19(3,23)16(18(22)25-5-2)14(15)12-9-7-6-8-10-12/h6-10,14-16,23H,4-5,11H2,1-3H3

Upstream product

• 110-89-4 piperidine 
• 620-80-4 ethyl 2-benzylidene acetoacetate 
• 64-17-5 ethanol 
• 141-97-9 ethyl acetoacetate 
• 2538-76-3 1,1'-benzylidenedipiperidine 
• 100-52-7 benzaldehyde 
• 141-52-6 sodium ethanolate 
• 538-51-2 benzylidene phenylamine 
• 109-89-7 diethylamine 
• 122-57-6 1-Phenylbut-1-en-3-one 
• 870-85-9 ethyl 3-methylaminocrotonate 
• 60-29-7 diethyl ether 
• 36276-69-4 2-methyl-2-piperidino-1-ethoxycarbonylethene 
• 74979-92-3 6-[(E)-4-Chloro-phenylimino]-4-hydroxy-4-methyl-2-phenyl-cyclohexane-1,3-dicarboxylic acid diethyl ester 

Downstream Products

• 19419-23-9 2,2'-phenylmethylene-bis(5,5-dimethylcyclohexane-1,3-dione) 
• 4165-96-2 3-phenylglutaric acid 
• 95486-25-2 diethyl 5-methyl-3?oxo-1,2,3,6-tetrahydro-[1,1'-biphenyl]-2,6-dicarboxylate 
• 77548-31-3 2-methyl-4-oxo-6-phenyl-cyclohex-2-enecarboxylic acid ethyl ester 
• 5337-88-2 3-methyl-5-phenyl-2-cyclohexen-1-one 
• 124502-22-3 8-Hydroxy-8-methyl-5-oxo-6-phenyl-5,5a,6,7,8,9-hexahydro-[1,2,4]triazolo[3,4-b]quinazoline-7-carboxylic acid ethyl ester 
• 124502-26-7 7-Hydroxy-7-methyl-4-oxo-5-phenyl-4,4a,5,6,7,8-hexahydro-1,2,3,3a,9-pentaaza-cyclopenta[b]naphthalene-6-carboxylic acid ethyl ester 
• 143210-85-9 4-Amino-9-methyl-6-oxo-7-phenyl-7,8-dihydro-6H-pyrido[1,2-a]quinazoline-8-carboxylic acid ethyl ester 
• 124502-20-1 8-Hydroxy-8-methyl-5-oxo-6-phenyl-5,5a,6,7,8,9-hexahydro-4b,10,11-triaza-benzo[b]fluorene-7-carboxylic acid ethyl ester 
• 124502-33-6 2-Ethyl-7-hydroxy-7-methyl-4-oxo-5-phenyl-5,6,7,8-tetrahydro-4H-1-thia-3,3a,9-triaza-cyclopenta[b]naphthalene-6-carboxylic acid ethyl ester 
• 124502-30-3 7-Hydroxy-7-methyl-3,4-dioxo-2,5-diphenyl-3,3a,4,4a,5,6,7,8-octahydro-2H-pyrazolo[3,4-b]quinoline-6-carboxylic acid ethyl ester 
• 127703-64-4 6-Amino-4-hydroxy-4-methyl-2-phenyl-cyclohexane-1,3-dicarboxylic acid diethyl ester 
• 127703-60-0 4,6-Dihydroxy-4-methyl-2-phenyl-cyclohexane-1,3-dicarboxylic acid diethyl ester 
• 127703-70-2 4-Hydroxy-6-[(Z)-hydroxyimino]-4-methyl-2-phenyl-cyclohexane-1,3-dicarboxylic acid diethyl ester 

Relevant articles and documents

A detailed investigation into the one-pot cascade reaction of ethyl 3,9-dimethyl-7-phenyl-6H-dibenzo-[b,d]pyran-6-one-8-carboxylate with phenylhydrazine

Abstract: When synthesizing cyclohexane-annulated pyrazolones from a cyclohexonedicarboxylate derivative with phenylhydrazine under the catalysis of sulfuric acid in the air, up to five products were finally obtained from the one-pot procedure. Among the

Synthesis of highly functionalized 3,4-cyclohexane-annelated coumarins

Efficient synthetic access to highly functionalized 3,4-cyclohexane-annelated coumarins has been achieved by combining two methods. First, the important intermediates multisubstituted cyclic ?2-keto esters were prepared conveniently by condensing a variet

An efficient regioselective synthesis of functionalized biphenyls via sequential reactions of aromatic aldehydes and β-keto esters or ketones

Knoevenagel/Michael/Aldol reactions of aromatic aldehydes and β-keto esters/ketones in a sequential manner yielded intermediate cyclohexanones in good yields. The latter, on oxidative aromatization with iodine, afforded functionalized biphenyls with at le

A facile synthesis of 4-aryl-5-alkoxycarbonyl-6-hydroxy-6-methyl-4,5,6,7-tetrahydro-3-hydroxy-2-(pyridin-2-yl)-indazoles and their nmr characterizations

A series of N-pyridinyl tetrahydroindazoles have been synthesized by a convenient and regioseletive method by taking cyclic 2-ketoesters as scaffolds. An optimum reaction condition was achieved by monitoring the reaction in different reaction c

Microwave assisted rapid and efficient synthesis of 2,1-benzoisoxazoles

A simple extremely fast and high yielding protocol has been developed for the synthesis of 2,1-benzisoxazoles under microwave irradiation.

Research on heterocyclic compounds. XLIII. Synthetic studies on 1,4-dihydropyridine derivatives

In order to obtain N-benzyl-3,5-dicarbethoxy-2,6-dimethyl-4-phenyl-1,4-dihydropyridine 1 as a lead compound of pharmacological interest, the classical Hantzsch synthetic method and the modified Collie procedure were used. However, only a very low yield of

A synthetic entry into fused pyran derivatives through carbon transfer reactions of 1,3-oxazinanes and oxazolidines with carbon nucleophiles

Acid catalysed condensations of various 2 substituted 1,3-oxazinanes 3 and 1,3-oxazolidines 4 with cyclic carbon nucleophiles viz. 5,5-dimethyl-1,3-cyclohexanedione and 1,3-cyclohexanedione furnish xanthene derivatives, whereas a Knoevenagel reaction proceeds with acyclic nucleophiles. In case of 4b and 4c, a unique synthesis of functionalised α-tetralones has emerged. Reactions of mixtures of cyclic and acyclic carbon nucleophiles with 3 provide some functionalised and partially reduced benzopyran derivatives.

1-ARYL- AND 1-BENZYL-3,5-DIETHOXYCARBONYL-1,4-DIHYDROPYRIDINES

The possibility has been studied of using anilines in the Hantzsch synthesis.It has been shown that, with the exception of those containing strong electron-accepting substituents, they take part in this reaction with the formation of 1-aryl-1,4-dihydropyridines.The reaction largely depends on the nature of the substituents in the aniline and in the benzaldehyde and is promoted by electron-accepting substituents in the aldehyde and electron-donating substituents in the amine.The mechanism of the reaction is discussed.A number of 1-benzyl-1,4-dihydroxypyridines have been synthesized.The UV, IR, and PMR spectra and the electro-oxidation of the compounds obtained have been studied.